EUVIMEDEUVIMED entdecken
Open Access

Scalable human neuronal models of tauopathy producing endogenous seed-competent 4R tau

Eliona Tsefou iD, Sumi Bez iD, Timothy J Y Birkle, Martha Foiani iD, Naoto Watamura iD, Mathieu Bourdenx iD, Daria Gavriouchkina iD, Emir Turkes iD, Samuel Crawford iD, Rachel Coneys, Adrian M Isaacs iD, Karen E Duff iD

Science Advances · 31.07.2026 · 12 (31)

DOI: 10.1126/sciadv.aeg1445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 31.07.2026. Verfasst von Eliona Tsefou und 11 weiteren Autor:innen. Beteiligte Einrichtung: UK Dementia Research Institute, University College London, London, UK. Hauptthemen laut MEDLINE: tau Proteins, Neurons, Tauopathies. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Rainwater Charitable Foundation, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accumulation of pathological four-repeat (4R) tau is central to several frontotemporal dementia (FTD) subtypes, but human neuronal models amenable to high-throughput screening of 4R tau–targeting therapies remain very limited. To address this, we developed induced pluripotent stem cell (iPSC)–derived i 3 Neuron (i 3 N) lines expressing >75% 4R tau, driven by FTD splice-shifting mutations (Ser 305 Asn; S305N or S305N/IVS10 + 3). These neurons develop hyperphosphorylated tau and demonstrate somatodendritic mislocalization. These i 3 N neurons develop endogenous seed-competent tau and present pentameric formyl thiophene acetic acid–(pFTAA)-positive tau assemblies after 28 days in culture. For scalable screening, we CRISPR-engineered an HiBiT luminescence tag at the endogenous MAPT locus into the S305N/IVS10 + 3 iPSC line, enabling precise quantification of tau levels and pharmacological responses. The model responded predictably to compounds affecting tau clearance, demonstrating its suitability for drug discovery. Overall, this i 3 N platform recapitulates key features of 4R tauopathy and provides a robust system to identify therapeutic modulators of pathological tau.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsNeuronsTauopathiesHumansInduced Pluripotent Stem CellsMutation

Substanzen

tau ProteinsMAPT protein, human

Autor:innen und Institutionen

  • UK Dementia Research Institute, University College London, London, UK.
  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

ORCID-Profile: Eliona Tsefou, Sumi Bez, Martha Foiani, Naoto Watamura, Mathieu Bourdenx, Daria Gavriouchkina, Emir Turkes, Samuel Crawford, Adrian M Isaacs, Karen E Duff

Förderung

  • NIA NIH HHS
  • Rainwater Charitable Foundation
  • Medical Research Council

Zitieren

APA

Tsefou, E., Bez, S., Birkle, T. J. Y., Foiani, M., Watamura, N., Bourdenx, M., Gavriouchkina, D., Turkes, E., Crawford, S., Coneys, R., Isaacs, A. M., & Duff, K. E. (2026). Scalable human neuronal models of tauopathy producing endogenous seed-competent 4R tau. Science Advances, 12(31). https://doi.org/10.1126/sciadv.aeg1445

Vancouver

Tsefou E, Bez S, Birkle TJY, Foiani M, Watamura N, Bourdenx M, et al. Scalable human neuronal models of tauopathy producing endogenous seed-competent 4R tau. Science Advances. 2026;12(31). doi:10.1126/sciadv.aeg1445

BibTeX
@article{Tsefou2026,
  author = {Tsefou, Eliona and Bez, Sumi and Birkle, Timothy J Y and Foiani, Martha and Watamura, Naoto and Bourdenx, Mathieu and Gavriouchkina, Daria and Turkes, Emir and Crawford, Samuel and Coneys, Rachel and Isaacs, Adrian M and Duff, Karen E},
  title = {Scalable human neuronal models of tauopathy producing endogenous seed-competent 4R tau},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {31},
  doi = {10.1126/sciadv.aeg1445}
}
Kostenlos starten →